This site is intended for healthcare professionals only
LoginRegister
Sanofi gets approval for 2 rare hematologic diseases medicines in ChinaSIL declares profit from operations growth as +6% vs previous year
Novartis Loses India Patent on Heart Failure Drug VymadaNovartis Told to Revise Protocol, Justify Sample Size in ITU512 Clinical Trial Proposal
Health Ministry Proposes Perpetual Validity for Medical Device LicencesHealth Ministry Notifies Cosmetics Rules 2025, Empowers States To Suspend Licences
Nasal SprayBiodeal Told To Justify Novel Delivery Claim In NPPA Exemption Plea For Midazolam Nasal Spray
Intas PharmaCDSCO Panel Accepts Phase I Trial Data for Intas' Denosumab Biosimilar
Torrent Pharma Slapped with Rs 41.33 Crore GST Penalty for Alleged Erroneous Export RefundsTorrent Pharma: USFDA concludes inspection at Vizag facility with zero observations
Meril names Faisal Shah MohammadMeril names Faisal Shah Mohammad as Business Head - Neurovascular
Gilead Sciences gets USFDA nod for new Biktarvy indicationGilead Sciences gets USFDA nod for new Biktarvy indication for people with HIV who are treatment...
Jubilant Wins Relief: Allahabad HC Bars Pharma Firms from Using Its Drug DossierUSFDA issues 4 observations for Jubilant Generics Roorkee facility
Centre Issues Medical Devices Amendment Rules 2026Medical Device Imports Still at 70%, India Spent Over USD 25 Billion in 5 Years: Parliament Informed
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsGranules India arm gets 1 USFDA observation for Hyderabad facility
CDSCO Panel Opines Key Changes in Phase III Study of Glimepiride-Linagliptin FDCCDSCO Panel Clears PURE & CURE's Sickle Cell Trial With Conditions On Sample Size, Sites
X